- Home
- PRME vs CNC Comparison
PRME vs CNC Comparison
Compare PRME & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRME | CNC |
|---|---|---|
| Founded | 2019 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 666.1M | 21.5B |
| IPO Year | 2022 | 2001 |
Fundamental Metrics
Financial Performance| Metric | PRME | CNC |
|---|---|---|
| Price | $3.62 | $33.31 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 17 |
| Target Price | $7.56 | ★ $41.94 |
| AVG Volume (30 Days) | 2.5M | ★ 5.6M |
| Earning Date | 03-03-2026 | 04-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.18 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $4,632,000.00 | ★ $194,777,000,000.00 |
| Revenue This Year | N/A | $8.29 |
| Revenue Next Year | N/A | $1.26 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 55.28 | 19.44 |
| 52 Week Low | $1.11 | $25.08 |
| 52 Week High | $6.94 | $66.03 |
Technical Indicators
Market Signals| Indicator | PRME | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 45.73 | 33.61 |
| Support Level | $3.19 | $33.27 |
| Resistance Level | $4.74 | $37.51 |
| Average True Range (ATR) | 0.23 | 1.48 |
| MACD | -0.03 | -0.38 |
| Stochastic Oscillator | 21.47 | 15.19 |
Price Performance
Historical ComparisonAbout PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About CNC Centene Corporation
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.